## **Core Concept**
Ketamine is a medication primarily used for starting and maintaining anesthesia. It induces a trance-like state while providing pain relief, sedation, and memory loss. The core mechanism of ketamine involves its action on specific receptors in the brain.

## **Why the Correct Answer is Right**
Ketamine acts as an antagonist at the **N-methyl-D-aspartate (NMDA) receptor**, which is a type of glutamate receptor. Glutamate is the most abundant excitatory neurotransmitter in the vertebrate nervous system. By blocking NMDA receptors, ketamine disrupts the normal functioning of glutamate, leading to its anesthetic effects. This action on NMDA receptors is crucial for its dissociative anesthetic properties.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While ketamine does have effects on various neurotransmitter systems, its primary and most well-known action related to its anesthetic effects is not through muscarinic receptors.
- **Option B:** Ketamine does not primarily act as a GABA receptor agonist; its main mechanism is not related to enhancing the effect of the neurotransmitter GABA (gamma-aminobutyric acid), which is more closely associated with the action of benzodiazepines and barbiturates.
- **Option C:** This option is not provided, but typically, other mechanisms might involve sigma receptors or opioid receptors to some extent, but these are not its primary mechanism of action.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that ketamine's use can be associated with psychedelic effects and dissociative symptoms due to its action on NMDA receptors. Additionally, it's worth noting that ketamine has shown promise in treating depression, particularly treatment-resistant depression, which is thought to be related to its effects on NMDA receptors and subsequent synaptic plasticity changes.

## **Correct Answer:** D. NMDA receptors.